RE: Superb MM effort today.14 Jun 2022 21:37
Gemstar, he makes absolutely no mention of therapeutics, the trial ongoing without any reason for it to be stopped, no mention of the potential of first readout just 4-8 weeks away being positive and the effect it would have on the SP, he literally just focuses on the balance sheet and diagnostics. He hasn’t mentioned potential Dox market share, he hasn’t valued the potential of PreCision if AVA6000 trials are a success, he hasn’t factored in the potential of ongoing trials with Point, Daewoong or LG, he hasn’t factored in the lack of product development costs since the LFT has been essentially dropped, he’s literally made the ****test argument possible based on his incredibly limited/zero knowledge of Avactas fundamentals and your post here shows you are also as thick as he is. Good luck you actual stupid twat. Binned.